Inventor
RAITANO ARTHUR B
US164 patents
⚠️ This page may combine multiple inventors who share the name “RAITANO ARTHUR B”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AGENSYS INC
43 patentsUS6329503B1Dec 11, 2001
Serpentine transmembrane antigens expressed in human cancers and uses thereof
AGENSYS INC147 citations99
US7507541B2Mar 24, 2009
36P6D5: secreted tumor antigen
AGENSYS INC89 citations98
US7494646B2Feb 24, 2009
Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
AGENSYS INC38 citations96
US7485299B2Feb 3, 2009
Serpentine transmembrane antigens expressed in human cancers and uses thereof
AGENSYS INC49 citations96
US7361338B2Apr 22, 2008
Methods to inhibit growth of prostate cancer cells
AGENSYS INC40 citations96
US7226594B2Jun 5, 2007
Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
AGENSYS INC25 citations96
US7166714B2Jan 23, 2007
Serpentine transmembrane antigens expressed in human cancers and uses thereof
AGENSYS INC35 citations96
US7053186B2May 30, 2006
Antibodies immunospecific for STEAP1
AGENSYS INC48 citations96
US6943235B1Sep 13, 2005
Transmembrane protein expressed in prostate cancer
AGENSYS INC34 citations96
US6887975B2May 3, 2005
Peptides derived from STEAP1
AGENSYS INC40 citations96
US6833438B1Dec 21, 2004
Serpentine transmembrane antigens expressed in human cancers and uses thereof
AGENSYS INC45 citations96
US8013128B2Sep 6, 2011
Antibodies and related molecules that bind to PSCA proteins
AGENSYS INC28 citations93
US7968090B2Jun 28, 2011
Nucleic acids and corresponding proteins entitled 191P4D12(b) useful in treatment and detection of cancer
AGENSYS INC19 citations93
US7884179B2Feb 8, 2011
Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer
AGENSYS INC20 citations93
US7667018B2Feb 23, 2010
Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
AGENSYS INC10 citations93
US7641905B2Jan 5, 2010
Methods of inducing an immune response
AGENSYS INC25 citations93
US7628989B2Dec 8, 2009
Methods of inducing an immune response
AGENSYS INC23 citations93
US7622564B2Nov 24, 2009
Prostate stem cell antigen (PSCA) variants and subsequences thereof
AGENSYS INC20 citations93
US7595379B2Sep 29, 2009
Antibodies and related molecules that bind to PSCA proteins
AGENSYS INC34 citations93
US7541442B2Jun 2, 2009
Antibodies and related molecules that bind to PSCA proteins
AGENSYS INC26 citations93
US7405290B2Jul 29, 2008
Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
AGENSYS INC23 citations93
US7244827B2Jul 17, 2007
Nucleic acid and corresponding protein entitled 24P4C12 useful in treatment and detection of cancer
AGENSYS INC20 citations93
US7067130B2Jun 27, 2006
Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
AGENSYS INC27 citations93
US6602501B1Aug 5, 2003
C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
AGENSYS INC13 citations93
US8013135B2Sep 6, 2011
Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
AGENSYS INC16 citations92
US8008442B2Aug 30, 2011
Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
AGENSYS INC22 citations92
US7968307B2Jun 28, 2011
Serpentine transmembrane antigens expressed in human cancers and uses thereof
AGENSYS INC14 citations92
US7947459B2May 24, 2011
Serpentine transmembrane antigens expressed in human cancers and uses thereof
AGENSYS INC19 citations92
US7939503B2May 10, 2011
Reduction of cell-cell communication in prostate cancer using STEAP-1 siRNA
AGENSYS INC17 citations92
US7928201B2Apr 19, 2011
Serpentine transmembrane antigens expressed in human cancers and uses thereof
AGENSYS INC16 citations92
US7811565B2Oct 12, 2010
Antibodies and related molecules that bind to 161P2F10B proteins
AGENSYS INC20 citations92
US7642054B2Jan 5, 2010
Serpentine transmembrane antigens expressed in human cancers and uses thereof
AGENSYS INC19 citations92
US7611904B2Nov 3, 2009
Serpentine transmembrane antigens expressed in human cancers and uses thereof
AGENSYS INC19 citations92
US7575749B2Aug 18, 2009
Serpentine transmembrane antigens expressed in human cancers and uses thereof
AGENSYS INC18 citations92
US7510840B1Mar 31, 2009
Method of inhibiting growth or survival of a cell by providing an anti-108P5H8 antibody
AGENSYS INC16 citations92
US7459539B2Dec 2, 2008
Antibody that binds zinc transporter protein 108P5H8
AGENSYS INC16 citations92
US7455991B2Nov 25, 2008
Serpentine transmembrane antigens expressed in human cancers and uses thereof
AGENSYS INC14 citations92
US7427399B2Sep 23, 2008
Antibodies and related molecules that bind to 161P2F10B proteins
AGENSYS INC21 citations92
US7223542B2May 29, 2007
36P6D5: secreted tumor antigen
AGENSYS INC13 citations92
US7037667B1May 2, 2006
Tumor antigen useful in diagnosis and therapy of prostate and colon cancer
AGENSYS INC41 citations92
US6893818B1May 17, 2005
Gene upregulated in cancers of the prostate
AGENSYS INC19 citations92
US7947276B2May 24, 2011
Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
AGENSYS INC18 citations91
US10597463B2Mar 24, 2020
Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
AGENSYS INC4 citations84
GENENTECH INC
2 patentsUNIV CALIFORNIA
1 patentAFAR DANIEL E
1 patentRAITANO ARTHUR B
1 patentGUDAS JEAN
1 patentUROGENESYS INC
1 patentShowing the top 50 of 164 patents by PatentIndex Score.